Article

Drosophila as a model system for studying lifespan and neuroprotective activities of plant-derived compounds

2011-07-21

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2b8840c7-0a75-5029-928f-21d02e9e45bb
DOI: 10.1016/j.aspen.2011.07.001

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drosophila as a model system for studying lifespan and neuroprotective activities of plant-derived compoundsDOI 10.1016/j.aspen.2011.07.001Read

Drosophila melanogaster as a model system in the study of pharmacological interventions in agingSemantic proximity Read

Drosophila melanogaster “a potential model organism” for identification of pharmacological properties of plants/plant-derived componentsSemantic proximity Read

Using Drosophila as a platform for drug discovery from natural products in Parkinson's diseaseSemantic proximity Read

Drosophila<em> melanogaster</em> as a Translational Model System to Explore the Impact of Phytochemicals on Human HealthSemantic proximity Read

Identification of structural features of selected flavonoids responsible for neuroprotection using a <i>Drosophila</i> model of Parkinson’s diseaseSemantic proximity Read

Neuroprotective effect of SuHeXiang Wan in Drosophila models of Alzheimer's diseaseSemantic proximity Read

An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer’s diseaseSemantic proximity Read

Drosophila as a model system to study autophagySemantic proximity Read

Exploring the versatility of Drosophila melanogaster as a model organism in biomedical research: a comprehensive reviewSemantic proximity Read

Neuroprotective potential of an <i>Ayurvedic</i> compound “Ras-Sindoor” on <i>Drosophila melanogaster</i> model of Parkinson’s diseaseSemantic proximity Read

Drosophila models pioneer a new approach to drug discovery for Parkinson's diseaseSemantic proximity Read

Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s diseaseSemantic proximity Read